Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella

Vaccine

Volumn 27, Issue 38, 2009, Pages 5214-5219

  Zhao, Zhongpeng ^a   Li, Min ^a   Luo, Deyan ^a   Xing, Li ^a   Wu, Shuo ^a   Duan, Yueqiang ^a   Yang, Penghui ^a   Wang, Xiliang ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Brucellosis; Fusion antigen; Salmonella

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VECTOR; BRUCELLA VACCINE; DNA VACCINE; HYBRID PROTEIN; LIVE VACCINE; RECOMBINANT PROTEIN; SUBUNIT VACCINE; UNCLASSIFIED DRUG; X 4072; X 4072 BL; X 4550; X 4550 BL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL STRAIN; BRUCELLA ABORTUS; BRUCELLOSIS; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; EUKARYOTIC CELL; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PLASMID; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPE; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BRUCELLA; BRUCELLA VACCINE; BRUCELLOSIS; FEMALE; IMMUNITY, CELLULAR; IMMUNITY, MUCOSAL; MICE; MICE, INBRED BALB C; PLASMIDS; RECOMBINANT PROTEINS; SALMONELLA TYPHIMURIUM; SPLEEN; VACCINES, DNA; VACCINES, SUBUNIT;

EID: 67651100867     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.06.075     Document Type: Article

References (39)

1. Godfroid J., Cloeckaert A., Liautard J.P., Kohler S., Fretin D., Walravens K., et al. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res 36 3 (2005) 313-326
2. Pappas G., Akritidis N., Bosilkovski M., Tsianos E., and Brucellosis. New Engl J Med 352 22 (2005) 2325-2336
3. Moriyon I., Grillo M.J., Monreal D., Gonzalez D., Marin C., Lopez-Goni I., et al. Rough vaccines in animal brucellosis: structural and genetic basis and present status. Vet Res 35 1 (2004) 1-38
4. Minas A., Minas M., Stournara A., and Tselepidis S. The "effects" of Rev-1 vaccination of sheep and goats on human brucellosis in Greece. Prev Vet Med 64 1 (2004) 41-47
5. Blasco J.M. A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats. Prev Vet Med 31 3-4 (1997) 275-283
6. Ashford D.A., di Pietra J., Lingappa J., Woods C., Noll H., Neville B., et al. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine 22 25-26 (2004) 3435-3439
7. Yu D.H., Hu X.D., and Cai H. A combined DNA vaccine encoding BCSP31, SOD, and L7/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL responses. DNA Cell Biol 26 6 (2007) 435-443
8. Yang X., Walters N., Robison A., Trunkle T., and Pascual D.W. Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization. Vaccine 25 12 (2007) 2261-2268
9. Luo D., Ni B., Li P., Shi W., Zhang S., Han Y., et al. Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice. Infect Immun 74 5 (2006) 2734-2741
10. Cassataro J., Pasquevich K.A., Estein S.M., Laplagne D.A., Zwerdling A., de la Barrera S., et al. A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev. 1 vaccination. Vaccine 25 32 (2007) 5958-5967
11. Oliveira S.C., and Splitter G.A. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine 14 10 (1996) 959-962
12. Oliveira S.C., and Splitter G.A. Subcloning and expression of the Brucella abortus L7/L12 ribosomal gene and T-lymphocyte recognition of the recombinant protein. Infect Immun 62 11 (1994) 5201-5204
13. Mallick A.I., Singha H., Chaudhuri P., Nadeem A., Khan S.A., Dar K.A., et al. Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection. Vaccine 25 18 (2007) 3692-3704
14. Kurar E., and Splitter G.A. Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune response. Vaccine 15 17-18 (1997) 1851-1857
15. Laplagne D.A., Zylberman V., Ainciart N., Steward M.W., Sciutto E., Fossati C.A., et al. Engineering of a polymeric bacterial protein as a scaffold for the multiple display of peptides. Proteins 57 4 (2004) 820-828
16. Sciutto E., Toledo A., Cruz C., Rosas G., Meneses G., Laplagne D., et al. Brucella spp. lumazine synthase: a novel antigen delivery system. Vaccine 23 21 (2005) 2784-2790
17. Velikovsky C.A., Cassataro J., Giambartolomei G.H., Goldbaum F.A., Estein S., Bowden R.A., et al. A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice. Infect Immun 70 5 (2002) 2507-2511
18. Velikovsky C.A., Goldbaum F.A., Cassataro J., Estein S., Bowden R.A., Bruno L., et al. Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used. Infect Immun 71 10 (2003) 5750-5755
19. Seleem M.N., Ali M., Boyle S.M., and Sriranganathan N. Vectors for enhanced gene expression and protein purification in Salmonella. Gene 421 1-2 (2008) 95-98
20. Saxena M., Coloe P.J., and Smooker P.M. Influence of promoter, gene copy number, and preexisting immunity on humoral and cellular responses to a vectored antigen delivered by a Salmonella enterica vaccine. Clin Vaccine Immunol 16 1 (2009) 78-87
21. Sadoff J.C., Ballou W.R., Baron L.S., Majarian W.R., Brey R.N., Hockmeyer W.T., et al. Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria. Science 240 4850 (1988) 336-338
22. Martinoli C., Chiavelli A., and Rescigno M. Entry route of Salmonella typhimurium directs the type of induced immune response. Immunity 27 6 (2007) 975-984
23. Haneberg B., Kendall D., Amerongen H.M., Apter F.M., Kraehenbuhl J.P., and Neutra M.R. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect Immun 62 1 (1994) 15-23
24. Gorvel J.P., Moreno E., and Moriyon I. Is Brucella an enteric pathogen?. Nat Rev 7 3 (2009) 250
25. Ko J., and Splitter G.A. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev 16 1 (2003) 65-78
26. Paranavitana C., Zelazowska E., Izadjoo M., and Hoover D. Interferon-gamma associated cytokines and chemokines produced by spleen cells from Brucella-immune mice. Cytokine 30 2 (2005) 86-92
27. Baldwin C.L., and Parent M. Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection. Vet Microbiol 90 1-4 (2002) 367-382
28. Deqiu S., Donglou X., and Jiming Y. Epidemiology and control of brucellosis in China. Vet Microbiol 90 1-4 (2002) 165-182
29. Izadjoo M.J., Bhattacharjee A.K., Paranavitana C.M., Hadfield T.L., and Hoover D.L. Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16 M. Infect Immun 72 7 (2004) 4031-4039
30. Cloeckaert A., Jacques I., Grillo M.J., Marin C.M., Grayon M., Blasco J.M., et al. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis. Vaccine 22 21-22 (2004) 2827-2835
31. Stabel T.J., Mayfield J.E., Morfitt D.C., and Wannemuehler M.J. Oral immunization of mice and swine with an attenuated Salmonella choleraesuis [delta cya-12 delta(crp-cdt)19] mutant containing a recombinant plasmid. Infect Immun 61 2 (1993) 610-618
32. Pontes D.S., Dorella F.A., Ribeiro L.A., Miyoshi A., Le Loir Y., Gruss A., et al. Induction of partial protection in mice after oral administration of Lactococcus lactis producing Brucella abortus L7/L12 antigen. J Drug Target 11 8-10 (2003) 489-493
33. Baloglu S., Boyle S.M., Vemulapalli R., Sriranganathan N., Schurig G.G., and Toth T.E. Immune responses of mice to vaccinia virus recombinants expressing either Listeria monocytogenes partial listeriolysin or Brucella abortus ribosomal L7/L12 protein. Vet Microbiol 109 1-2 (2005) 11-17
34. Pizza M., Scarlato V., Masignani V., Giuliani M.M., Arico B., Comanducci M., et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287 5459 (2000) 1816-1820
35. Stabel T.J., Mayfield J.E., Tabatabai L.B., and Wannemuehler M.J. Oral immunization of mice with attenuated Salmonella typhimurium containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus. Infect Immun 58 7 (1990) 2048-2055
36. Stabel T.J., Mayfield J.E., Tabatabai L.B., and Wannemuehler M.J. Swine immunity to an attenuated Salmonella typhimurium mutant containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus. Infect Immun 59 9 (1991) 2941-2947
37. Bai Y., Zhang Y.L., Wang J.D., Zhang Z.S., and Zhou D.Y. Construction of attenuated Salmonella typhimurium Strain expressing Helicobacter pylori conservative region of adhesin antigen and its immunogenicity. World J Gastroenterol 10 17 (2004) 2498-2502
38. Pan Z., Zhang X., Geng S., Cheng N., Sun L., Liu B., et al. Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus. Vaccine 27 7 (2009) 1018-1023
39. Yingst S., and Hoover D.L. T cell immunity to brucellosis. Crit Rev Microbiol 29 4 (2003) 313-331